FineMark National Bank & Trust’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
– Sell
-177
Closed -$2K – 1306
2016
Q2
$2K Hold
177
– – ﹤0.01% 1181
2016
Q1
$2K Hold
177
– – ﹤0.01% 1116
2015
Q4
$2K Hold
177
– – ﹤0.01% 1142
2015
Q3
$2K Hold
177
– – ﹤0.01% 1220
2015
Q2
$2K Hold
177
– – ﹤0.01% 1224
2015
Q1
$2K Hold
177
– – ﹤0.01% 1232
2014
Q4
$2K Hold
177
– – ﹤0.01% 1255
2014
Q3
$1K Hold
177
– – ﹤0.01% 1300
2014
Q2
$1K Hold
177
– – ﹤0.01% 1319
2014
Q1
$2K Hold
177
– – ﹤0.01% 1267
2013
Q4
$2K Hold
177
– – ﹤0.01% 1284
2013
Q3
$1K Hold
177
– – ﹤0.01% 1357
2013
Q2
$1K Buy
+177
New +$1.03K ﹤0.01% 1317

Other funds holding ACLS

FineMark National Bank & Trust's ACLS Position: Q3 2016 in Review

FineMark National Bank & Trust sold out of Axcelis (ACLS) in Q3 2016, closing a stake of 177 shares — an estimated $2K sold.

FineMark National Bank & Trust first reported a position in ACLS in Q2 2013 and held it in 13 quarters. The position peaked at $2K in Q2 2016. 84 funds tracked by Wall St. Rank hold ACLS as of Q3 2016.

  • FineMark National Bank & Trust reported no remaining Axcelis position as of Q3 2016 after selling out during the quarter.
  • FineMark National Bank & Trust sold 177 Axcelis shares in Q3 2016, an estimated $2K.
  • FineMark National Bank & Trust first reported a position in Axcelis in Q2 2013 and held it in 13 quarters.
  • FineMark National Bank & Trust's Axcelis position peaked at $2K in Q2 2016.
  • 84 funds tracked by Wall St. Rank held Axcelis as of Q3 2016.

Based on FineMark National Bank & Trust's 13F filing for Q3 2016, filed 10 Nov 2016.